Business
Is now the time to invest into the CSL (ASX:CSL) share price?
The CSL Limited (ASX: CSL) share price has taken a hammering in recent weeks, falling as low as $242.00 at the start of this month. At the time of writing, CSL shares are trading for $260.57, up 0.15%. The global biotech has struggled to regain its limelight due to COVID-19 vaccine concerns as well as plasma collections.
However, with the vaccine’s latest developments, is now the time to invest into CSL shares?
Vaccine update
The CSL share price has barely lifted off despite the positive news released on over the weekend.
According to reports, the Australian Therapeutic Goods Administration (TGA) advised it had approved local production of…
-
Business17 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business13 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business9 hours agoDicker Data rides the AI trend to double digit growth
-
Business12 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy